Some of the nation's major pharmaceutical manufacturers are taking steps to ensure their prescription painkillers cannot be abused by patients more interested in a high than in relieving pain. The practice, which came to light a decade ago with the widespread use of OxyContin, often involves using a drug in a manner in which it was not intended, such as disabling extended-release elements.

Related Summaries